Exam 3 - Random Multiple Choice Flashcards
What type of breath should be used with a dry powder inhaler?
A. Quick and shallow
B. Slow and deep
C. Quick and deep
D. Shallow and slow
C. Quick and deep
When would you use a LABA as monotherapy in asthma patients?
A. Intermittent
B. Severe
C. Moderate
D. Never
D. Never
Which of these is a LABA?
A. Fluticasone (Arnuity)
B. Albuterol (Ventolin)
C. Salmeterol (Serevent)
D. Tiotropium (Spiriva)
c. Salmeterol (Serevent)
What are advantages of a Dry Powder Inhaler
A. Increased experience
B. Less expensive
C. Requires less coordination
D. Uses a propellant
c. Requires less coordination
Which of these is an environmental risk factor for asthma? (select all that apply)
a. allergen exposure
b. antibiotic exposure
c. exposures to second hand smoke
d. genetic inheritance
a, b, c
Which symptom frequency would be classified as moderate persistent asthma?
A. Nighttime awakening >1 time/week
B. Nighttime awakening <2 times/month
C. No interference with normal activity
D. SABA use several times a day
a. Nighttime awakening >1 time/week
Which patient would be considered for a COPD diagnosis? (select all that apply)
A. A child with a history of asthma
B. >40 year old patient with a chronic cough, dyspnea and sputum production
C. A patient with shortness of breath during exercise
D. An adult with a history of smoking >1 pack per day for 10 years
B, D
Presence of a post bronchodilator FEV1/FVC of <0.7 confirms the presence airflow limitation consistent with COPD
A. True
B. False
A. True
what state is appropriate for a COPD patient with 2 exacerbations, CAT score of 5 and mMRC of 1?
a. A
b. B
c. C
d. D
c. C
What COPD staging is appropriate for a patient with 1 exacerbation, CAT score of 15 and an
mMRC of 2?
A. A
B. B
C. C
D. D
B. B
true or false: initial therapy for a GOLD group C should consist of a LAMA
true
When should you consider an ICS therapy for a patient living with COPD?
A. Concurrent asthma diagnosis
B. Eosinophils >200
C. History of pneumonia
D. History of Mycobacteria infection
A. Concurrent asthma diagnosis
Which medication is likely to cause a dry mouth and blurred vision?
A. Albuterol
B. Formoterol
C. Prednisone
D. Tiotropium
D. Tiotropium
Which medication class when used as monotherapy may result in an increased risk of asthma related death?
A. Ipratropium
B. Levalbuterol
C. Prednisone
D. Salmeterol
d. Salmeterol
what is the generic name for Pulmicort?
a. Mometasone
b. Beclamethasone
c. Budesonide
d. Fluticasone
c. Budesonide
How can a patient prevent oral thrush when using an ICS?
A. Do not put tongue on the mouth piece
B. Gargle with listerine after use
C. Only take it at night
D. Wash mouth out with water and spit after use
D. Wash mouth out with water and spit after use
CS is a 67-year-old man who is being seen for treatment of newly diagnosed chronic obstructive pulmonary disease (COPD). His past medical history is significant for hypertension, diabetes, cirrhosis (Child-Pugh C), and gastroesophageal reflux disease (GERD). Which medication should be avoided in CS?
a. azithromycin
b. Roflumilast
c. Olodaterol
d. Aclidinium
b. Roflumilast
(Roflumilast is hepatically metabolized and is contraindicated in moderate to severe hepatic impairment, like with Child-Pugh B or C)
BD is a 59-year-old man with chronic obstructive pulmonary disease (COPD), hypertension, and dyslipidemia. He reports to your pharmacy complaining of developing a tremor since starting one of his medications. Which medication is the most likely cause?
A. Ipratropium
B. Tiotropium
C. Fluticasone
D. Prednisone
E. Albuterol
E. Albuterol
(tremors is a common side effect of beta-agonists. Other common effects include tachycardia and central nervous system stimulation/excitation)
AJ is a 5-year-old who has been experiencing daytime rhinorrhea, night-time cough that woke him two times this past week, enuresis (involuntary urination) two times in the past months, and has a history of reflux. Which symptom is most likely to warrant a work up for asthma?
a. Rhinorrhea
b. Cough
c. Reflux
d. Enuresis
b. Cough
Which one of the following medications would be contraindicated with Daliresp?
a. carbamazepine
b. simvastatin
c. clarithromycin
d. fluconazole
a. carbamazepine
(Daliresp is contraindicated for CYP3A4 inducers, such as carbamazepine)
AZ is a 67-year-old white male who is receiving 32 mg/h of aminophylline in the hospital. He is ready to be changed to oral theophylline. What would the daily dose of theophylline be that would equal 32 mg/h of aminophylline? Aminophylline’s salt factor is 0.8.
a. 614 mg
b. 768 mg
c. 300 mg
d. 900 mg
a. 614 mg
(32 mg/h * 24 hours = 768 mg amionphylline in a daily dose. Multiply by 0.8 to get 614.4)
CP is a 65-year-old man with chronic obstructive pulmonary disease (COPD), classified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines as patient group C. He is currently using albuterol inhaler as needed (prn), salmeterol inhaler twice a day, and tiotropium inhaler once a day. His COPD is still uncontrolled with frequent symptoms and a recent exacerbation. What recommendations would you make to his medication regimen?
a. add theophylline once daily
b. change salmeterol inhaler to fluticasone/salmeterol combination inhaler scheduled twice a day
c. add an oral corticosteroid once daily
d. change tiotropium inhaler to ipratropium inhaler scheduled four times a day
e. do not make any changes
b. change salmeterol inhaler to fluticasone/salmeterol combination inhaler scheduled twice a day
Select the formulation of the corticosteroid that should be utilized in maintenance therapy for chronic obstructive pulmonary disease (COPD).
a. IV/injection (methylprednisolone
b. Oral (prednisone
c. Inhalation (fluticasone)
d. nasal (fluticasone)
c. Inhalation (fluticasone)
(inhalation is the preferred formulation/dosage route for maintenance therapy with COPD; this method minimizes adverse reactions; nasal preparations are used for allergic rhinitis)
PL is a 75-year-old man who has been experiencing increased dyspnea (shortness of breath) for the past month. He was diagnosed with chronic obstructive pulmonary disease (COPD) 3 years ago and has been taking albuterol metered-dose inhaler on an as-needed (prn) basis. He has not had any exacerbations within the past year, and he has a Modified Medical Research Council (mMRC) score of 2. Which of the following is the best choice for changing his medication regimen?
a. add scheduled inhaled tiotropium and continue prn albuterol
b. add scheduled inhaled fluticasone and continue prn albuterol
c. add prn inhaled salmeterol and continue prn albuterol
d. add scheduled oral theophylline and continue prn albuterol
e. no changes are necessary at this time
a. add scheduled inhaled tiotropium and continue prn albuterol
(patient is in group B since he has had 1 or less exacerbation/year and his mMRC is ≥ 2; guidelines recommend adding regular treatment with one or more long-acting bronchodilators; B is incorrect because they haven’t had any exacerbations lately, so no ICS is needed; C is incorrect because salmeterol should be scheduled, not prn)